Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Open accessThe DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Abstract
Inflammatory bowel diseases, which include Crohn’s disease and ulcerative colitis, affect several million individuals worldwide. Crohn’s disease and ulcerative colitis are complex diseases that are heterogeneous at the clinical, immunological, molecular, genetic, and microbial levels. Individual contributing factors have been the focus of extensive research. As part of the Integrative Human Microbiome Project (HMP2 or iHMP), we followed 132 subjects for one year each to generate integrated longitudinal molecular profiles of host and microbial activity during disease (up to 24 time points each; in total 2,965 stool, biopsy, and blood specimens). Here we present the results, which provide a comprehensive view of functional dysbiosis in the gut microbiome during inflammatory bowel disease activity. We demonstrate a characteristic increase in facultative anaerobes at the expense of obligate anaerobes, as well as molecular disruptions in microbial transcription (for example, among clostridia), metabolite pools (acylcarnitines, bile acids, and short-chain fatty acids), and levels of antibodies in host serum. Periods of disease activity were also marked by increases in temporal variability, with characteristic taxonomic, functional, and biochemical shifts. Finally, integrative analysis identified microbial, biochemical, and host factors central to this dysregulation. The study’s infrastructure resources, results, and data, which are available through the Inflammatory Bowel Disease Multi’omics Database ( http://ibdmdb.org ), provide the most comprehensive description to date of host and microbial activities in inflammatory bowel diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This relative absence of biomarkers for active UC may result both from its generally more benign phenotype (IBDMDB Investigators et al., 2019) and from the smaller number of active UC samples (n = 23) compared with active CD samples (n = 76); as a result, we focused our subsequent analyses on expression differences within the CD subcohort.”
From Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3 (2021) · cites this paper as IBDMDB Investigators et al., 2019
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This network of mechanistic associations identified several key components that are central to the alterations seen in IBD, highlighting octanoyl carnitine, several lipids and short-chain fatty acids, the taxa Faecalibacterium, Subdoligranulum, Roseburia, Alistipes, and Escherichia, some at both the metagenomic and metatranscriptomic levels, and host regulators of interleukins49.”
From The Integrative Human Microbiome Project (2019) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Multiple lines of evidence point towards central roles of gut microbiome perturbations in the pathogenesis of IBD.”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [152]
The cited source says what the claim attributes to it.
In the citing paper
“These studies, which have now reached the first stage of completion49–51, together provide a wealth of information and insights about not only microbial dynamics, but also associated human host responses and microbial inter-relationships.”
From The Integrative Human Microbiome Project (2019) · cites this paper as [49]
In the citing paper
“The authors could then use the 17 top taxa in their ranked list to identify which individuals are dysbiotic, an approach that demonstrated similar or better performance than the GMWI2 or another published metric called the “dysbiotic score”.195”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [195]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
Wickham, H. (2016) · Use R! · doi:10.1007/978-3-319-24277-4 · Cited by 33,115
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,826
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
Self-citationUPARSE: highly accurate OTU sequences from microbial amplicon reads
Edgar, R. C. (2013) · Nature Methods · doi:10.1038/nmeth.2604 · Cited by 16,707
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Fast and sensitive protein alignment using DIAMOND
Buchfink, B., Xie, C., & Huson, D. H. (2015) · Nature Methods · doi:10.1038/nmeth.3176 · Cited by 14,201
Cited by
Items 101–200 of 1,010
Problems with the concept of gut microbiota dysbiosis
Brüssow, H. (2020) · Microbial Biotechnology · doi:10.1111/1751-7915.13479 · Cited by 250
“One of the three subprojects of HMP deals with the gut microbiota in inflammatory bowel disease (IBD), where an impressive array of multiomics technologies have been applied to nearly 3000 stool, biopsy and blood samples taken repetitively over one year from 132 patients (Lloyd-Price et al., 2019).”
BackgroundMicrobiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities
Iliev, I. D., Ananthakrishnan, A. N., & Guo, C.-J. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01163-0 · Cited by 249
“An increase in primary bile acids, cholate and acylcarnitines, which are modified by microorganisms, was found to be characteristic for individuals with IBD 15 .”
InfluentialSelf-citationProximal colon–derived O-glycosylated mucus encapsulates and modulates the microbiota
Bergstrom, K., Shan, X., Casero, D., Batushansky, A., Lagishetty, V., Jacobs, J. P., Hoover, C., Kondo, Y., Shao, B., Gao, L., et al. (2020) · Science · doi:10.1126/science.aay7367 · Cited by 245
Self-citationInflammatory Bowel Diseases and Gut Microbiota
Haneishi, Y., Furuya, Y., Hasegawa, M., Picarelli, A., Rossi, M., & Miyamoto, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043817 · Cited by 242
“Moreover, a multi-omics analysis including metagenomic, metatranscriptomic, metabolomic, and other analyses revealed that the gut microbiota and their metabolites in CD and UC were different during the active and remission phases [44].”
BackgroundClooney, A. G., Eckenberger, J., Laserna-Mendieta, E., Sexton, K. A., Bernstein, M. T., Vagianos, K., Sargent, M., Ryan, F. J., Moran, C., Sheehan, D., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321106 · Cited by 244
Self-citationNguyen, L. H., Örtqvist, A. K., Cao, Y., Simon, T. G., Roelstraete, B., Song, M., Joshi, A. D., Staller, K., Chan, A. T., Khalili, H., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30267-3 · Cited by 244
Self-citationLi, Z., Wang, Y., Liu, J., Rawding, P., Bu, J., Hong, S., & Hu, Q. (2021) · Advanced Materials · doi:10.1002/adma.202102580 · Cited by 244
Rühlemann, M. C., Hermes, B. M., Bang, C., Doms, S., Moitinho-Silva, L., Thingholm, L. B., Frost, F., Degenhardt, F., Wittig, M., Kässens, J., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00747-1 · Cited by 241
Lee, J. W. J., Plichta, D., Hogstrom, L., Borren, N. Z., Lau, H., Gregory, S. M., Tan, W., Khalili, H., Clish, C., Vlamakis, H., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.06.019 · Cited by 228
Self-citationMultiomics to elucidate inflammatory bowel disease risk factors and pathways
Agrawal, M., Allin, K. H., Petralia, F., Colombel, J.-F., & Jess, T. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00593-y · Cited by 225
Neutrophils: from IBD to the gut microbiota
Danne, C., Skerniskyte, J., Marteyn, B., & Sokol, H. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00871-3 · Cited by 222
“…in total 2,965 stool, biopsy and blood specimens) provided a comprehensive view of functional dysbiosis in the gut microbiome during IBD activity and demonstrated disruptions in microbial transcriptional and metabolic activity, with effects on acylcarnitine, bile acid and SCFA levels in faeces 88 .”
Bile Acid Signaling in Inflammatory Bowel Diseases
Fiorucci, S., Carino, A., Baldoni, M., Santucci, L., Costanzi, E., Graziosi, L., Distrutti, E., & Biagioli, M. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06715-3 · Cited by 224
Big data in IBD: big progress for clinical practice
Seyed Tabib, N. S., Madgwick, M., Sudhakar, P., Verstockt, B., Korcsmaros, T., & Vermeire, S. (2020) · Gut · doi:10.1136/gutjnl-2019-320065 · Cited by 223
“51”
Leveraging diet to engineer the gut microbiome
Wolter, M., Grant, E. T., Boudaud, M., Steimle, A., Pereira, G. V., Martens, E. C., & Desai, M. S. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00512-7 · Cited by 211
Standardized multi-omics of Earth’s microbiomes reveals microbial and metabolite diversity
Shaffer, J. P., Nothias, L.-F., Thompson, L. R., Sanders, J. G., Salido, R. A., Couvillion, S. P., Brejnrod, A. D., Lejzerowicz, F., Haiminen, N., Huang, S., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01266-x · Cited by 220
Self-citationThe human microbiome in disease and pathology
Manos, J. (2022) · APMIS · doi:10.1111/apm.13225 · Cited by 220
Debaryomyces is enriched in Crohn’s disease intestinal tissue and impairs healing in mice
Jain, U., Ver Heul, A. M., Xiong, S., Gregory, M. H., Demers, E. G., Kern, J. T., Lai, C.-W., Muegge, B. D., Barisas, D. A. G., Leal-Ekman, J. S., et al. (2021) · Science · doi:10.1126/science.abd0919 · Cited by 218
Self-citationThe promise of the gut microbiome as part of individualized treatment strategies
Schupack, D. A., Mars, R. A. T., Voelker, D. H., Abeykoon, J. P., & Kashyap, P. C. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00499-1 · Cited by 217
Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside
Yang, M., Gu, Y., Li, L., Liu, T., Song, X., Sun, Y., Cao, X., Wang, B., Jiang, K., & Cao, H. (2021) · Nutrients · doi:10.3390/nu13093143 · Cited by 213
(2020) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2020.04.003 · Cited by 212
van der Lelie, D., Oka, A., Taghavi, S., Umeno, J., Fan, T.-J., Merrell, K. E., Watson, S. D., Ouellette, L., Liu, B., Awoniyi, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23460-x · Cited by 205
Sasso, J. M., Ammar, R. M., Tenchov, R., Lemmel, S., Kelber, O., Grieswelle, M., & Zhou, Q. A. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00127 · Cited by 204
Russo, E., Giudici, F., Fiorindi, C., Ficari, F., Scaringi, S., & Amedei, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02754 · Cited by 204
“Moreover, a recently published human study demonstrates that the GM and the molecular functional profile in terms of transcriptome andmetabolome, and the host immune factors, are crucial to IBD (32).”
BackgroundImmunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics
Lu, Q., Yang, M.-F., Liang, Y.-J., Xu, J., Xu, H.-M., Nie, Y.-Q., Wang, L.-S., Yao, J., & Li, D.-F. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s353038 · Cited by 200
Raygoza Garay, J. A., Turpin, W., Lee, S.-H., Smith, M. I., Goethel, A., Griffiths, A. M., Moayyedi, P., Espin-Garcia, O., Abreu, M., Aumais, G. L., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.05.032 · Cited by 201
Self-citationEffects of Rare Microbiome Taxa Filtering on Statistical Analysis
Cao, Q., Sun, X., Rajesh, K., Chalasani, N., Gelow, K., Katz, B., Shah, V. H., Sanyal, A. J., & Smirnova, E. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.607325 · Cited by 198
“The initial findings and multi-omic datasets from these studies were published in the Nature family of journals in May and June of 2019 (Lloyd-Price et al., 2019), and 16S data are publicly available through the HMP Data Coordination Center (HMP-DACC) and HMP2Data Bioconductor package (Stansfield et…”
MethodGuo, P., Wang, W., Xiang, Q., Pan, C., Qiu, Y., Li, T., Wang, D., Ouyang, J., Jia, R., Shi, M., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.07.028 · Cited by 195
Dorrestein, P., Gentry, E., Collins, S., Panitchpakdi, M., Belda-Ferre, P., Stewart, A., Wang, M., Jarmusch, A., Avila-Pacheco, J., Plichta, D., et al. (2021) · doi:10.21203/rs.3.rs-820302/v1 · Cited by 197
Self-citationXu, S., Li, X., Zhang, S., Qi, C., Zhang, Z., Ma, R., Xiang, L., Chen, L., Zhu, Y., Tang, C., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02878-8 · Cited by 196
The role of oral bacteria in inflammatory bowel disease
Read, E., Curtis, M. A., & Neves, J. F. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00488-4 · Cited by 193
Gut microbiota bridges dietary nutrients and host immunity
Fan, L., Xia, Y., Wang, Y., Han, D., Liu, Y., Li, J., Fu, J., Wang, L., Gan, Z., Liu, B., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2346-1 · Cited by 189
“Furthermore, vitamin B5 is particularly depleted in the gut during IBD (Lloyd-Price et al., 2019).”
BackgroundMucosal immune response in biology, disease prevention and treatment
Zhou, X., Wu, Y., Zhu, Z., Lu, C., Zhang, C., Zeng, L., Xie, F., Zhang, L., & Zhou, F. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02043-4 · Cited by 186
Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis
Galipeau, H. J., Caminero, A., Turpin, W., Bermudez-Brito, M., Santiago, A., Libertucci, J., Constante, M., Raygoza Garay, J. A., Rueda, G., Armstrong, S., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.004 · Cited by 190
Self-citationRoles of Macrophages in the Development and Treatment of Gut Inflammation
Han, X., Ding, S., Jiang, H., & Liu, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.625423 · Cited by 190
DeepMicrobes: taxonomic classification for metagenomics with deep learning
Liang, Q., Bible, P. W., Liu, Y., Zou, B., & Wei, L. (2020) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqaa009 · Cited by 188
“For example, the previous study found that Alistipes species, such as Alistipes shahii, Alistipes finegoldii and Alistipes putredinis are depleted in IBD (10).”
MethodResultInfluentialYeshi, K., Ruscher, R., Hunter, L., Daly, N. L., Loukas, A., & Wangchuk, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051273 · Cited by 184
Another renaissance for bile acid gastrointestinal microbiology
Ridlon, J. M., & Gaskins, H. R. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00896-2 · Cited by 183
“…evidence through examination of longitudinal metabolomic and metagenomic profiles of stool samples from individuals in the HMP2 IBDMDB cohort 199 (132 participants with Crohn’s disease, with ulcerative colitis or without IBD (control)) and found that isoalloLCA and its biosynthetic genes…”
Worby, C. J., Schreiber, H. L., Straub, T. J., van Dijk, L. R., Bronson, R. A., Olson, B. S., Pinkner, J. S., Obernuefemann, C. L. P., Muñoz, V. L., Paharik, A. E., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01107-x · Cited by 188
Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation
Thibaut, M. M., & Bindels, L. B. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.12.006 · Cited by 184
Limeta, A., Ji, B., Levin, M., Gatto, F., & Nielsen, J. (2020) · JCI Insight · doi:10.1172/jci.insight.140940 · Cited by 185
OmicsNet 2.0: a web-based platform for multi-omics integration and network visual analytics
Zhou, G., Pang, Z., Lu, Y., Ewald, J., & Xia, J. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac376 · Cited by 179
“Previous study has shown that over representation of Escherichia coli and related species in IBD might be explained by their better ability to produce glutathione for oxidative stresses resistance (54).”
InfluentialRadiotherapy and the gut microbiome: facts and fiction
Liu, J., Liu, C., & Yue, J. (2021) · Radiation Oncology · doi:10.1186/s13014-020-01735-9 · Cited by 183
“Considering each ‘-omic’ technology provides its own unique perspective of the microbiome and its communication with the host, multiple ‘-omic’ approaches can be applied simultaneously to the same sample to obtain integrated results [115].”
BackgroundMicrobial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases
Oka, A., & Sartor, R. B. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06090-z · Cited by 182
Amyloid–Polyphenol Hybrid Nanofilaments Mitigate Colitis and Regulate Gut Microbial Dysbiosis
Hu, B., Yu, S., Shi, C., Gu, J., Shao, Y., Chen, Q., Li, Y., & Mezzenga, R. (2020) · ACS Nano · doi:10.1021/acsnano.9b09125 · Cited by 181
Metabolomics and Multi-Omics Integration: A Survey of Computational Methods and Resources
Eicher, T., Kinnebrew, G., Patt, A., Spencer, K., Ying, K., Ma, Q., Machiraju, R., & Mathé, E. A. (2020) · Metabolites · doi:10.3390/metabo10050202 · Cited by 177
Zhang, S., Nie, Q., Sun, Y., Zuo, S., Chen, C., Li, S., Yang, J., Hu, J., Zhou, X., Yu, Y., et al. (2024) · Microbiome · doi:10.1186/s40168-024-01896-9 · Cited by 174
“Moreover, alterations in metabolic patterns have been observed in IBD patients [7].”
BackgroundDietary fiber intake, the gut microbiome, and chronic systemic inflammation in a cohort of adult men
Ma, W., Nguyen, L. H., Song, M., Wang, D. D., Franzosa, E. A., Cao, Y., Joshi, A., Drew, D. A., Mehta, R., Ivey, K. L., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00921-y · Cited by 178
Self-citationAldars-García, L., Chaparro, M., & Gisbert, J. P. (2021) · Microorganisms · doi:10.3390/microorganisms9050977 · Cited by 178
“Overall, longitudinal studies in IBD (only 15% of the included studies) indicate that there is decreased stability in the microbiota composition in UC and CD patients [18,23,25,118,131,132,138,149].”
BackgroundIn vitro interaction network of a synthetic gut bacterial community
Weiss, A. S., Burrichter, A. G., Durai Raj, A. C., von Strempel, A., Meng, C., Kleigrewe, K., Münch, P. C., Rössler, L., Huber, C., Eisenreich, W., et al. (2022) · The ISME Journal · doi:10.1038/s41396-021-01153-z · Cited by 176
“Function-related patterns in native microbial communities can be identified by systems biology approaches, combining metagenomics, metatranscriptomics, and metabolomics analyses [14].”
BackgroundThe intestinal clock drives the microbiome to maintain gastrointestinal homeostasis
Heddes, M., Altaha, B., Niu, Y., Reitmeier, S., Kleigrewe, K., Haller, D., & Kiessling, S. (2022) · Nature Communications · doi:10.1038/s41467-022-33609-x · Cited by 172
Multi-omic approaches for host-microbiome data integration
Chetty, A., & Blekhman, R. (2024) · Gut Microbes · doi:10.1080/19490976.2023.2297860 · Cited by 171
“60 Several additional studies have also performed multi-omics analysis by finding feature-by-feature correlations.”
BackgroundWei, S., Bahl, M. I., Baunwall, S. M. D., Hvas, C. L., & Licht, T. R. (2021) · Applied and Environmental Microbiology · doi:10.1128/aem.00395-21 · Cited by 172
The effects of oral microbiota on health
Tuganbaev, T., Yoshida, K., & Honda, K. (2022) · Science · doi:10.1126/science.abn1890 · Cited by 173
Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease
Mehta, R. S., Mayers, J. R., Zhang, Y., Bhosle, A., Glasser, N. R., Nguyen, L. H., Ma, W., Bae, S., Branck, T., Song, K., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02217-7 · Cited by 168
Self-citationGenetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome
Jin, W.-B., Li, T.-T., Huo, D., Qu, S., Li, X. V., Arifuzzaman, M., Lima, S. F., Shi, H.-Q., Wang, A., Putzel, G. G., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.035 · Cited by 169
Microbiome Multi-Omics Network Analysis: Statistical Considerations, Limitations, and Opportunities
Jiang, D., Armour, C. R., Hu, C., Mei, M., Tian, C., Sharpton, T. J., & Jiang, Y. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00995 · Cited by 170
“Recent examples include a somatic eQTL analysis using linear regression to model the association between gene expression and the mutation status of linked loci while accounting for various covariates including DNA methylation and gene copy number variation (Zhang et al., 2018). Moore and Hoen (2019) discussed the use…”
MethodRole of gut microbiota in identification of novel TCM-derived active metabolites
Lin, T.-L., Lu, C.-C., Lai, W.-F., Wu, T.-S., Lu, J.-J., Chen, Y.-M., Tzeng, C.-M., Liu, H.-T., Wei, H., & Lai, H.-C. (2021) · Protein & Cell · doi:10.1007/s13238-020-00784-w · Cited by 171
Zhou, X., Shen, X., Johnson, J. S., Spakowicz, D. J., Agnello, M., Zhou, W., Avina, M., Honkala, A., Chleilat, F., Chen, S. J., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.02.012 · Cited by 167
Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities
Plevris, N., & Lees, C. W. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.01.024 · Cited by 168
Priya, S., Burns, M. B., Ward, T., Mars, R. A. T., Adamowicz, B., Lock, E. F., Kashyap, P. C., Knights, D., & Blekhman, R. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01121-z · Cited by 165
The relationship between the gut microbiome and host gene expression: a review
Nichols, R. G., & Davenport, E. R. (2021) · Human Genetics · doi:10.1007/s00439-020-02237-0 · Cited by 164
Ma, S., Shungin, D., Mallick, H., Schirmer, M., Nguyen, L. H., Kolde, R., Franzosa, E., Vlamakis, H., Xavier, R., & Huttenhower, C. (2022) · Genome biology · doi:10.1186/s13059-022-02753-4 · Cited by 164
“The existence of subtypes within gut microbial communities has been a major open question in human microbiome studies, and it is of particular importance within IBD as a potential explanation for heterogeneity in disease etiology and treatment response [6, 9].”
InfluentialSelf-citationZhu, L., Yu, T., Wang, W., Xu, T., Geng, W., Li, N., & Zan, X. (2024) · Advanced Materials · doi:10.1002/adma.202308728 · Cited by 161
Nickols, W. A., Kuntz, T. M., Shen, J., Maharjan, S., Mallick, H., Franzosa, E. A., Thompson, K. N., Nearing, J. T., & Huttenhower, C. (2026) · Nature Methods · doi:10.1038/s41592-025-02923-9 · Cited by 245
“When applied to the HMP2 Inflammatory Bowel Disease Multi-omics (IBDMDB) cohort 23 , it replicated known associations but revealed that 77% of associations were prevalence based.”
InfluentialSelf-citationResistant starch, microbiome, and precision modulation
Dobranowski, P. A., & Stintzi, A. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1926842 · Cited by 159
Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity
Su, X., Gao, Y., & Yang, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1127743 · Cited by 159
Host microbiota can facilitate pathogen infection
Stevens, E. J., Bates, K. A., & King, K. C. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009514 · Cited by 161
Nardone, O. M., de Sire, R., Petito, V., Testa, A., Villani, G., Scaldaferri, F., & Castiglione, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.694217 · Cited by 177
“Recently, a comprehensive description of qualitative alterations in the gut microbiome of 132 patients affected by IBD has shown the presence of a functional dysbiosis in the gut microbiome during flairs of the disease with an increase in facultative anaerobes over obligate anaerobes, as well as molecular dysregulatio…”
BackgroundThe Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease
Thomas, J. P., Modos, D., Rushbrook, S. M., Powell, N., & Korcsmaros, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.829525 · Cited by 156
“Furthermore, amajormulti-omics profiling of 103 IBD patients (n=38UC, 65CD)overone year revealed significant enrichment of the PBA CA and its glycine and taurine conjugates, in dysbiotic samples fromCDpatients in comparison to non-dysbiotic samples (29).”
ResultMetabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease
Sultan, S., El-Mowafy, M., Elgaml, A., Ahmed, T. A. E., Hassan, H., & Mottawea, W. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.715506 · Cited by 156
Faecal metabolome and its determinants in inflammatory bowel disease
Vila, A. V., Hu, S., Andreu‐Sánchez, S., Collij, V., Jansen, B. H., Augustijn, H. E., Bolte, L. A., Ruigrok, R. A. A. A., Abu-Ali, G., Giallourakis, C. C., et al. (2023) · Gut · doi:10.1136/gutjnl-2022-328048 · Cited by 204
Wang, M., Fu, R., Xu, D.-Q., Chen, Y., Yue, S., Zhang, S., & Tang, Y. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116879 · Cited by 170
Recipient factors in faecal microbiota transplantation: one stool does not fit all
Danne, C., Rolhion, N., & Sokol, H. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00441-5 · Cited by 154
Impact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease
Banfi, D., Moro, E., Bosi, A., Bistoletti, M., Cerantola, S., Crema, F., Maggi, F., Giron, M. C., Giaroni, C., & Baj, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041623 · Cited by 171
“Decreased indole levels during dysbiosis are associated with altered immune and epithelial barrier functions [316,317].”
BackgroundHost-microbiota interaction-mediated resistance to inflammatory bowel disease in pigs
Zhao, X., Jiang, L., Fang, X., Guo, Z., Wang, X., Shi, B., & Meng, Q. (2022) · Microbiome · doi:10.1186/s40168-022-01303-1 · Cited by 170
“Increases in these bacteria are a frequent finding in IBDassociated dysbiosis, suggesting that these bacteria might function as potentially harmful microbes and play roles in the pathogenesis of the disease.”
ResultInfluentialPriorities for the next 10 years of human microbiome research
Proctor, L. (2019) · Nature · doi:10.1038/d41586-019-01654-0 · Cited by 150
Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury
Rath, E., & Haller, D. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00514-x · Cited by 173
Intestinal transgene delivery with native E. coli chassis allows persistent physiological changes
Russell, B. J., Brown, S. D., Siguenza, N., Mai, I., Saran, A. R., Lingaraju, A., Maissy, E. S., Dantas Machado, A. C., Pinto, A. F. M., Sanchez, C., et al. (2022) · Cell · doi:10.1016/j.cell.2022.06.050 · Cited by 151
“Large microbiome resource studies, such as the Human Microbiome Project and American Gut Project (Lloyd-Price et al., 2019; McDonald et al., 2018), show limited detection of E. coli by 16S rRNA gene sequencing from fecal samples, whereas infants have higher levels (Chu et al., 2017), suggesting that E. coli abundance…”
Self-citationLongitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Björk, J. R., Bolte, L. A., Maltez Thomas, A., Lee, K. A., Rossi, N., Wind, T. T., Smit, L. M., Armanini, F., Asnicar, F., Blanco-Miguez, A., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02803-3 · Cited by 156
Integrated microbiota and metabolite profiles link Crohn’s disease to sulfur metabolism
Metwaly, A., Dunkel, A., Waldschmitt, N., Raj, A. C. D., Lagkouvardos, I., Corraliza, A. M., Mayorgas, A., Martinez-Medina, M., Reiter, S., Schloter, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17956-1 · Cited by 149
Yang, Z., Liu, F., Zhu, X., Suo, F., Jia, Z., & Yao, S. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i24.3609 · Cited by 157
Large-scale association analyses identify host factors influencing human gut microbiome composition
Kurilshikov, A., Medina-Gomez, C., Bacigalupe, R., Radjabzadeh, D., Wang, J., Demirkan, A., Roy, C. I. L., Raygoza Garay, J. A., Finnicum, C. T., Liu, X., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.26.173724 · Cited by 145
Self-citationTang, S., Liu, W., Zhao, Q., Li, K., Zhu, J., Yao, W., & Gao, X. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113280 · Cited by 154
Noninvasive, microbiome-based diagnosis of inflammatory bowel disease
Zheng, J., Sun, Q., Zhang, M., Liu, C., Su, Q., Zhang, L., Xu, Z., Lu, W., Ching, J. Y. L., Tang, W., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03280-4 · Cited by 177
Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis
Baumgartner, M., Lang, M., Holley, H., Crepaz, D., Hausmann, B., Pjevac, P., Moser, D., Haller, F., Hof, F., Beer, A., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.06.024 · Cited by 156
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Thomas, A. M., Fidelle, M., Routy, B., Kroemer, G., Wargo, J. A., Segata, N., & Zitvogel, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00785-8 · Cited by 141
Machine learning for data integration in human gut microbiome
Li, P., Luo, H., Ji, B., & Nielsen, J. (2022) · Microbial Cell Factories · doi:10.1186/s12934-022-01973-4 · Cited by 140
“…including the Metagenomics of the Human Intestinal Tract (MetaHIT) consortium [21, 22] and the Human Microbiome Project (HMP, including two phases HMP1 and HMP2) [11, 23, 24], the TEDDY study [6, 25], have enriched our knowledge of the human gut microbiota and its impact on human physiology.”
BackgroundA guide to human microbiome research: study design, sample collection, and bioinformatics analysis
Qian, X., Chen, T., Xu, Y., Chen, L., Fu-xiang, S., Lu, M., & Liu, Y. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000871 · Cited by 166
“In addition, microbiome analysis methods have improved rapidly due to the emergence of advanced technologies or pipelines, including Quantitative Insights Into Microbial Ecology (QIIME) 2([13]) and multi-omics analyses,([1,9]) which are broadly used in medical and non-medical research.”
BackgroundMethodLippa, K. A., Aristizabal‐Henao, J. J., Beger, R. D., Bowden, J. A., Broeckling, C. D., Beecher, C., Davis, W. C., Dunn, W. B., Flores, R., Goodacre, R., et al. (2022) · Metabolomics · doi:10.1007/s11306-021-01848-6 · Cited by 165
Evaluation and comparison of short chain fatty acids composition in gut diseases
Niccolai, E., Baldi, S., Ricci, F., Russo, E., Nannini, G., Menicatti, M., Poli, G., Taddei, A., Bartolucci, G., Calabrò, A. S., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i36.5543 · Cited by 139
Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome
Hillestad, E. M. R., van der Meeren, A., Nagaraja, B. H., Bjørsvik, B. R., Haleem, N., Benítez‐Páez, A., Sanz, Y., Hausken, T., Lied, G. A., Lundervold, A., et al. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i4.412 · Cited by 168
Compositional and functional features of the female premenopausal and postmenopausal gut microbiota
Zhao, H., Chen, J., Li, X., Sun, Q., Qin, P., & Wang, Q. (2019) · FEBS Letters · doi:10.1002/1873-3468.13527 · Cited by 138
Diet fuelling inflammatory bowel diseases: preclinical and clinical concepts
Adolph, T. E., & Zhang, J. (2022) · Gut · doi:10.1136/gutjnl-2021-326575 · Cited by 160
Gut microbiota-derived metabolites tune host homeostasis fate
Kim, S., Seo, S., & Kweon, M. (2024) · Seminars in Immunopathology · doi:10.1007/s00281-024-01012-x · Cited by 169
Single-cell approaches in human microbiome research
Lloréns-Rico, V., Simcock, J. A., Huys, G. R. B., & Raes, J. (2022) · Cell · doi:10.1016/j.cell.2022.06.040 · Cited by 136
Harbison, J. E., Roth‐Schulze, A. J., Giles, L. C., Tran, C. D., Ngui, K., Penno, M. A. S., Thomson, R. L., Wentworth, J. M., Colman, P. G., Craig, M. E., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12865 · Cited by 162
How bile acids and the microbiota interact to shape host immunity
Lee, M. H., Nuccio, S.-P., Mohanty, I., Hagey, L. R., Dorrestein, P. C., Chu, H., & Raffatellu, M. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-024-01057-x · Cited by 143
Metabolomic analysis in inflammatory bowel disease: A systematic review
Gallagher, K., Catesson, A., Griffin, J. L., Holmes, E., & Williams, H. R. T. (2021) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjaa227 · Cited by 133
Metatranscriptomics for the Human Microbiome and Microbial Community Functional Profiling
Zhang, Y., Thompson, K. N., Branck, T. A., Yan, Y., Nguyen, L. H., Franzosa, E. A., & Huttenhower, C. (2021) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-031121-103035 · Cited by 167
Self-citationCross-species RNA-seq for deciphering host–microbe interactions
Westermann, A. J., & Vogel, J. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00326-y · Cited by 134
Metadata
- Authors
- Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., Andrews, E., Ajami, N. J., Bonham, K. S., Brislawn, C. J., Casero, D., Courtney, H., Gonzalez, A., Graeber, T. G., Hall, A. B., Lake, K., Landers, C. J., Mallick, H., Plichta, D. R., Prasad, M., Rahnavard, G., Sauk, J., Shungin, D., Vázquez-Baeza, Y., White, R. A., IBDMDB Investigators, Bishai, J., Bullock, K., Deik, A., Dennis, C., Kaplan, J. L., Khalili, H., McIver, L. J., Moran, C. J., Nguyen, L., Pierce, K. A., Schwager, R., Sirota-Madi, A., Stevens, B. W., Tan, W., ten Hoeve, J. J., Weingart, G., Wilson, R. G., Yajnik, V., Braun, J., Denson, L. A., Jansson, J. K., Knight, R., Kugathasan, S., McGovern, D. P. B., Petrosino, J. F., Stappenbeck, T. S., Winter, H. S., Clish, C. B., Franzosa, E. A., Vlamakis, H., Xavier, R. J., & Huttenhower, C.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Broad Institute (US)
- Baylor College of Medicine (US)
- Pacific Northwest National Laboratory (US)
- University of California, Los Angeles (US)
- Cincinnati Children's Hospital Medical Center (US)
- Cedars-Sinai Medical Center (US)
- Emory University (US)
- University of California San Diego (US)
- Washington University in St. Louis (US)
- Corresponding author
- Huttenhower, Curtis
- ORCID
- Arze, Cesar
- Ananthakrishnan, Ashwin N.
- Schirmer, Melanie
- Ajami, Nadim J.
- Bonham, Kevin S.
- Brislawn, Colin J.
- Casero, David
- Graeber, Thomas G.
- Hall, A. Brantley
- Mallick, Himel
- Plichta, Damian R.
- Sauk, Jenny
- Shungin, Dmitry
- Bullock, Kevin
- Deik, Amy
- Khalili, Hamed
- McIver, Lauren J.
- Nguyen, Long
- Pierce, Kerry A.
- Yajnik, Vijay
- Knight, Rob
- McGovern, Dermot P. B.
- Winter, Harland S.
- Clish, Clary B.
- Franzosa, Eric A.
- Vlamakis, Hera
- Xavier, Ramnik J.
- Huttenhower, Curtis
- Venue
- Nature
- Published
- 2019-05-29
- Volume
- 569
- Issue
- 7758
- Pages
- 655-662
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6650278
- OpenAlex
- W2947189704
- Cited by
- 3,143
- References
- 101
- Citations by year
- 2026: 500 · 2025: 555 · 2024: 498 · 2023: 402 · 2022: 441 · 2021: 452 · 2020: 247 · 2019: 42
- FWCI
- 98.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- National Science Foundation (1053486, DEAC05–76RL01830, 76RL01830)
- U.S. Department of Energy (DE-AC05–76RL01830, 76RL01830, AC05-76RL01830, DE-AC05?)
- Battelle (AC05-76RL01830, DE- AC05-76RL01830, DE-AC05)
- Leona M. and Harry B. Helmsley Charitable Trust (P01DK046763, U01DK062413)
- Harvard T.H. Chan School of Public Health
- Crohn's and Colitis Foundation (563526)
- Broad Institute
- Vetenskapsrådet (4.1-2016-00416)
- National Institutes of Health (DBI-1053486, UL1TR001881, DE-AC05-76RL01830)
- National Human Genome Research Institute (R01HG005969)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK046763, R24DK110499, U54DK102557, U01DK062413, P30DK078392, P30DK043351, P30DK040561)
- National Institute of Dental and Craniofacial Research (U54DE023798)
- National Center for Advancing Translational Sciences
- Army Research Office (W911NF-11-1-0473, W911NF, W911NF-11)
- Pacific Northwest National Laboratory (DEAC0576RL01830, 76RL01830)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- inflammatory bowel disease, Crohn's disease, ulcerative colitis, gut microbiota, dysbiosis, multi-omics, facultative anaerobes, obligate anaerobes, Clostridia, acylcarnitines, bile acids, short-chain fatty acids, serum antibodies, disease activity, temporal variation, host-microbe interactions
- MeSH terms
- Gastrointestinal Microbiome, Animals, Fungi, Health, Humans, Phylogeny, Species Specificity, Viruses, Inflammatory Bowel Diseases, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.